AW

ALEX WHALEN

THE MCMANUS GROUP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
15
last 3 years
Filings
38
4 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023.
Medicare/Medicaid · 2024 Q3
Issues related to Artificial Intelligence approval in Medical Devices H.R.1557 - BID Act of 2023 as part of H.R. 1/S. 947- Lower Energy Costs Act H.R.8818 - American privacy Rights Act of 2024
Health Issues · 2024 Q3
Issues relating to proposed Local Coverage Determinations (LCDs) and associated Local Coverage Articles (LCAs) restricting patient access to wound care products
Medicare/Medicaid · 2024 Q3
Access and reimbursement in Medicare Parts B & D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 H.R. 2666 - Medicaid VBPs for Patients (MVP) Act Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, S.1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R.8261 - Preserving Telehealth, Hospital, and Ambulance Access Act, H.R. 7623 - Telehealth Modernization Act of 2024 H.R.5547/S. 476- Maintaining Investments in New Innovation Act S.2764/H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act of 2023 S.3131 - ORPHAN Cures Act, H.R.5539 - Optimizing Research Progress Hope and New Cures Act
Medicare/Medicaid · 2024 Q3
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program and H.R.8574 - To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes. Issues related to commercial delinking of PBMs in H.R.6283 - DRUG Act, S.1542 - DRUG Act
Health Issues · 2024 Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers including H.R.1694 - Emergency Care Improvement Act.
Medicare/Medicaid · 2024 Q3

Clients

2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
2024 · 1 filing
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 1 filing
$██,███ / qtrUnlock

Filing history

2024 Q3
INFUSION PROVIDERS ALLIANCE
Q3lda.gov →
2024 Q3
LARGE UROLOGY GROUP PRACTICE ASSOCIATION
Q3lda.gov →
2024 Q3
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
Q3lda.gov →
2024 Q3
AMGEN
Q3lda.gov →
2024 Q3
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION
Q3lda.gov →
2024 Q3
ZIMMER BIOMET
Q3lda.gov →
2024 Q3
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC.
Q3lda.gov →
2024 Q3
EMD SERONO, INC.
Q3lda.gov →
2024 Q3
GRAIL, INC.
Q3lda.gov →
2024 Q3
VIVEX BIOLOGICS
Q3lda.gov →
2024 Q3
AMBULATORY SURGERY CENTER ASSOCIATION
Q3lda.gov →
2024 Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q3lda.gov →
Showing recent filings · full history on lda.gov